Fernando Fervenza

34PUBLICATIONS
50CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)PharmacogenomicsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 08, 2026
Long-term eculizumab treatment failure in C3 glomerulonephritis: two case reports.

|Jun 05, 2026
Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy.

|Apr 08, 2026
A case of adrenal insufficiency after initiation of targeted-release budesonide formulation (Nefecon) in a patient with IgA nephropathy.

Trisha D Laxamana, Fernando C Fervenza, Richard J Glassock

|Feb 19, 2026
Finerenone with empagliflozin in CKD with diabetes (CONFIDENCE): only a blood pressure effect? Likely!

Maria J Soler, Paola Romagnani, Fernando C Fervenza

|Feb 18, 2026
Microscopic hematuria in IgA nephropathy: a biomarker of disease activity.

Jürgen Floege, Fernando C Fervenza, Rosanna Coppo

|Dec 03, 2025
Pegcetacoplan for Treatment of C3 Glomerulopathy and Immune-Complex MPGN.

Ladan Zand, Fernando C Fervenza

Pageof 6

Frequent Collaborators

13 joint publications

Sanjeev Sethi

4 joint publications

Maria Soler

3 joint publications

Marta Casal Moura

3 joint publications

Kenneth J Warrington